WallStreetZenWallStreetZen

NASDAQ: PRCT
Procept Biorobotics Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PRCT

Based on 8 analysts offering 12 month price targets for Procept Biorobotics Corp

Min Forecast
$38.00+26.88%
Avg Forecast
$51.13+70.7%
Max Forecast
$62.00+107.01%

Should I buy or sell PRCT stock?

Based on 8 analysts offering ratings for Procept Biorobotics Corp.

Strong Buy
Strong Buy
6 analysts 75%
Buy
1 analysts 12.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PRCT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PRCT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their PRCT stock forecasts and price targets.

PRCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-18
lockedlocked$00.00+00.00%2025-12-12
lockedlocked$00.00+00.00%2025-12-08
lockedlocked$00.00+00.00%2025-12-02
lockedlocked$00.00+00.00%2025-11-05
Piper Sandler
Bottom 4%
4
Strong BuyReiterates$50.00+66.94%2025-11-05
Wells Fargo
Top 40%
61
Strong BuyMaintains$51.00+70.28%2025-11-05
Oppenheimer
Top 27%
74
BuyUpgrades$60.00+100.33%2025-09-02

1 of 1

Forecast return on equity

Is PRCT forecast to generate an efficient return?

Company
2.32%
Industry
31.01%
Market
236.81%
PRCT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRCT forecast to generate an efficient return on assets?

Company
1.73%
Industry
14.68%
PRCT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRCT earnings per share forecast

What is PRCT's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
-$1.16
Avg 2 year Forecast
-$0.63
Avg 3 year Forecast
-$0.40

PRCT revenue forecast

What is PRCT's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$431.0M+43.7%
Avg 2 year Forecast
$538.3M+79.49%
Avg 3 year Forecast
$630.2M+110.13%
PRCT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRCT revenue growth forecast

How is PRCT forecast to perform vs Medical Devices companies and vs the US market?

Company
28.47%
Industry
9.47%
Market
23.28%
PRCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRCT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PRCT$29.95$51.13+70.70%Strong Buy
AXGN$34.51$36.14+4.73%Strong Buy
AHCO$10.64$15.00+40.98%Strong Buy
AORT$40.34$49.36+22.36%Buy
INSP$68.14$125.79+84.60%Buy
View Top Medical Device Stocks

Procept Biorobotics Stock Forecast FAQ

Is Procept Biorobotics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: PRCT) stock is to Strong Buy PRCT stock.

Out of 8 analysts, 6 (75%) are recommending PRCT as a Strong Buy, 1 (12.5%) are recommending PRCT as a Buy, 1 (12.5%) are recommending PRCT as a Hold, 0 (0%) are recommending PRCT as a Sell, and 0 (0%) are recommending PRCT as a Strong Sell.

If you're new to stock investing, here's how to buy Procept Biorobotics stock.

What is PRCT's earnings growth forecast for 2026-2028?

(NASDAQ: PRCT) Procept Biorobotics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 17.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.79%.

Procept Biorobotics's earnings in 2026 is -$84,582,000.On average, 16 Wall Street analysts forecast PRCT's earnings for 2026 to be -$65,059,441, with the lowest PRCT earnings forecast at -$83,784,356, and the highest PRCT earnings forecast at -$30,509,710. On average, 14 Wall Street analysts forecast PRCT's earnings for 2027 to be -$35,097,342, with the lowest PRCT earnings forecast at -$57,499,068, and the highest PRCT earnings forecast at $19,948,656.

In 2028, PRCT is forecast to generate -$22,228,503 in earnings, with the lowest earnings forecast at -$31,213,780 and the highest earnings forecast at -$12,321,229.

What is PRCT's revenue growth forecast for 2026-2028?

(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 28.47% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.47%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.28%.

Procept Biorobotics's revenue in 2026 is $299,907,000.On average, 16 Wall Street analysts forecast PRCT's revenue for 2026 to be $24,081,436,715, with the lowest PRCT revenue forecast at $22,714,646,429, and the highest PRCT revenue forecast at $25,407,435,632. On average, 14 Wall Street analysts forecast PRCT's revenue for 2027 to be $30,080,003,245, with the lowest PRCT revenue forecast at $27,681,694,205, and the highest PRCT revenue forecast at $32,247,533,712.

In 2028, PRCT is forecast to generate $35,214,128,002 in revenue, with the lowest revenue forecast at $33,190,764,294 and the highest revenue forecast at $37,315,721,734.

What is PRCT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: PRCT) forecast ROA is 1.73%, which is lower than the forecast US Medical Devices industry average of 14.68%.

What is PRCT's Price Target?

According to 8 Wall Street analysts that have issued a 1 year PRCT price target, the average PRCT price target is $51.13, with the highest PRCT stock price forecast at $62.00 and the lowest PRCT stock price forecast at $38.00.

On average, Wall Street analysts predict that Procept Biorobotics's share price could reach $51.13 by Dec 18, 2026. The average Procept Biorobotics stock price prediction forecasts a potential upside of 70.7% from the current PRCT share price of $29.95.

What is PRCT's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: PRCT) Procept Biorobotics's current Earnings Per Share (EPS) is -$1.52. On average, analysts forecast that PRCT's EPS will be -$1.16 for 2026, with the lowest EPS forecast at -$1.50, and the highest EPS forecast at -$0.55. On average, analysts forecast that PRCT's EPS will be -$0.63 for 2027, with the lowest EPS forecast at -$1.03, and the highest EPS forecast at $0.36. In 2028, PRCT's EPS is forecast to hit -$0.40 (min: -$0.56, max: -$0.22).

What is PRCT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: PRCT) forecast ROE is 2.32%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.